Form 4/A for OMDA Omada Health, Inc.
Accepted 2026-06-24 19:26:11 ET · period of report 2026-06-12 · accession 0001610717-26-000295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2026-06-24 19:26 | 2026-06-12 | OMDA | Shao Wei-Li | Pres | S - Sale | $17.24 | -4,037 | 316.8K | -1% | -$69.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | S | D | 4,037 | $17.24 | 316,790 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This Form 4/A is being filed solely to correct the number of shares reported as sold on June 12, 2026, and the total number of shares beneficially owned. Due to an administrative error by the broker, the original Form 4 filing overstated the number of shares sold under the Reporting Person's 10b5-1 trading plan. This amendment corrects the error to reflect the actual number of shares sold and beneficially owned. (F3) This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |